Literature DB >> 9435904

Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 1. Method and validations.

S S So1, M Karplus.   

Abstract

The utility of genetic neural network (GNN) to obtain quantitative structure-activity relationships (QSAR) from molecular similarity matrices is described. In this application, the corticosteroid-binding globulin (CBG) binding affinity of the well-known steroid data set is examined. Excellent predictivity can be obtained through the use of either electrostatic or shape properties alone. Statistical validation using a standard randomization test indicates that the results are not due to chance correlations. Application of GNN on the combined electrostatic and shape matrix produces a six-descriptor model with a cross-validated r2 value of 0.94. The model is superior to those obtained from partial least-squares and genetic regressions, and it also compares favorably with the results for the same data set from other established 3D QSAR methods. The theoretical basis for the use of molecular similarity in QSAR is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9435904     DOI: 10.1021/jm970487v

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  20 in total

1.  A comparative study of ligand-receptor complex binding affinity prediction methods based on glycogen phosphorylase inhibitors.

Authors:  S S So; M Karplus
Journal:  J Comput Aided Mol Des       Date:  1999-05       Impact factor: 3.686

2.  Evaluation of designed ligands by a multiple screening method: application to glycogen phosphorylase inhibitors constructed with a variety of approaches.

Authors:  S S So; M Karplus
Journal:  J Comput Aided Mol Des       Date:  2001-07       Impact factor: 3.686

3.  Protein-ligand binding free energy estimation using molecular mechanics and continuum electrostatics. Application to HIV-1 protease inhibitors.

Authors:  V Zoete; O Michielin; M Karplus
Journal:  J Comput Aided Mol Des       Date:  2003-12       Impact factor: 3.686

Review 4.  Neural networks as robust tools in drug lead discovery and development.

Authors:  David A Winkler
Journal:  Mol Biotechnol       Date:  2004-06       Impact factor: 2.695

Review 5.  Genetic algorithm optimization in drug design QSAR: Bayesian-regularized genetic neural networks (BRGNN) and genetic algorithm-optimized support vectors machines (GA-SVM).

Authors:  Michael Fernandez; Julio Caballero; Leyden Fernandez; Akinori Sarai
Journal:  Mol Divers       Date:  2010-03-20       Impact factor: 2.943

6.  QSAR models of cytochrome P450 enzyme 1A2 inhibitors using CoMFA, CoMSIA and HQSAR.

Authors:  J Sridhar; M Foroozesh; C L Klein Stevens
Journal:  SAR QSAR Environ Res       Date:  2011-10-17       Impact factor: 3.000

7.  Validation tools for variable subset regression.

Authors:  Knut Baumann; Nikolaus Stiefl
Journal:  J Comput Aided Mol Des       Date:  2004 Jul-Sep       Impact factor: 3.686

8.  Prediction of plasma protein binding of drugs using Kier-Hall valence connectivity indices and 4D-fingerprint molecular similarity analyses.

Authors:  Jianzhong Liu; Liu Yang; Yi Li; Dahua Pan; Anton J Hopfinger
Journal:  J Comput Aided Mol Des       Date:  2005-11-03       Impact factor: 3.686

9.  3D-chiral atom, atom-type, and total non-stochastic and stochastic molecular linear indices and their applications to central chirality codification.

Authors:  Yovani Marrero-Ponce; Juan A Castillo-Garit
Journal:  J Comput Aided Mol Des       Date:  2005-06       Impact factor: 3.686

10.  Novel approach to evolutionary neural network based descriptor selection and QSAR model development.

Authors:  Zeljko Debeljak; Viktor Marohnić; Goran Srecnik; Marica Medić-Sarić
Journal:  J Comput Aided Mol Des       Date:  2006-04-11       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.